GB2076403B - 1-(4-chlorobenzhydryl)-4-(2,3-bishydrocypropyl) piperazine - Google Patents

1-(4-chlorobenzhydryl)-4-(2,3-bishydrocypropyl) piperazine

Info

Publication number
GB2076403B
GB2076403B GB8115827A GB8115827A GB2076403B GB 2076403 B GB2076403 B GB 2076403B GB 8115827 A GB8115827 A GB 8115827A GB 8115827 A GB8115827 A GB 8115827A GB 2076403 B GB2076403 B GB 2076403B
Authority
GB
United Kingdom
Prior art keywords
bishydrocypropyl
chlorobenzhydryl
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8115827A
Other languages
English (en)
Other versions
GB2076403A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selvi and C SpA
Original Assignee
Selvi and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selvi and C SpA filed Critical Selvi and C SpA
Publication of GB2076403A publication Critical patent/GB2076403A/en
Application granted granted Critical
Publication of GB2076403B publication Critical patent/GB2076403B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
GB8115827A 1980-05-23 1981-05-22 1-(4-chlorobenzhydryl)-4-(2,3-bishydrocypropyl) piperazine Expired GB2076403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22283/80A IT1140978B (it) 1980-05-23 1980-05-23 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche

Publications (2)

Publication Number Publication Date
GB2076403A GB2076403A (en) 1981-12-02
GB2076403B true GB2076403B (en) 1983-11-16

Family

ID=11194137

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8115827A Expired GB2076403B (en) 1980-05-23 1981-05-22 1-(4-chlorobenzhydryl)-4-(2,3-bishydrocypropyl) piperazine

Country Status (8)

Country Link
JP (1) JPS5731678A (US20040157337A1-20040812-M00001.png)
BE (1) BE888811A (US20040157337A1-20040812-M00001.png)
DE (1) DE3118162C2 (US20040157337A1-20040812-M00001.png)
ES (1) ES502429A0 (US20040157337A1-20040812-M00001.png)
FR (1) FR2482965A1 (US20040157337A1-20040812-M00001.png)
GB (1) GB2076403B (US20040157337A1-20040812-M00001.png)
IT (1) IT1140978B (US20040157337A1-20040812-M00001.png)
NL (1) NL8102361A (US20040157337A1-20040812-M00001.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3611276A1 (de) * 1986-04-04 1987-11-26 Unilever Nv Verpackung mit margarine oder aehnlichem brotaufstrich
JPH01226575A (ja) * 1988-02-25 1989-09-11 Mitsubishi Plastics Ind Ltd もずくの包装体
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
MX2007001240A (es) 2004-08-02 2007-03-23 Astrazeneca Ab Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
HU227074B1 (en) 2005-12-08 2010-06-28 Egis Gyogyszergyar Nyrt An optically active carbamic acid derivative, method for producing the same and use as a pharmaceutical intermediate
ES2361343T3 (es) * 2007-11-21 2011-06-16 Synthon B.V. Procedimiento para obtener n-(difenilmetil)piperazinas.
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines

Also Published As

Publication number Publication date
FR2482965B1 (US20040157337A1-20040812-M00001.png) 1984-11-23
JPS6135189B2 (US20040157337A1-20040812-M00001.png) 1986-08-12
FR2482965A1 (fr) 1981-11-27
DE3118162A1 (de) 1982-02-18
DE3118162C2 (de) 1984-07-26
NL8102361A (nl) 1981-12-16
ES8203352A1 (es) 1982-04-01
ES502429A0 (es) 1982-04-01
BE888811A (nl) 1981-08-28
IT1140978B (it) 1986-10-10
GB2076403A (en) 1981-12-02
JPS5731678A (en) 1982-02-20
IT8022283A0 (it) 1980-05-23

Similar Documents

Publication Publication Date Title
AU552345B2 (en) N-heterocyclyl piperidines, piperazines and homopiperazines
LU85537A1 (fr) 1-heteroaryl-4-((2,5-pyrrolidinedion-1-yl)alcoyl)-piperazines
GB2142631B (en) 1,2,4-triazol-3-one antidepressants
GB2076403B (en) 1-(4-chlorobenzhydryl)-4-(2,3-bishydrocypropyl) piperazine
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
GB2073738B (en) Piperazine derivatives
NZ197456A (en) 1-(3,4-fluoralkylenedioxyphenyl)-3-benzoyl(thio)ureas
GB2067562B (en) Cinnamoyl piperazines derivatives
GB2073752B (en) 2,6-diaminobularines
PT72641B (en) Novel 1-(4-aryl-ciclohexyl)piperidine derivatives
SG46991G (en) 1-(2-aryl-2-halo-1-ethenyl)-1h-azoles
GB2063868B (en) 1-(8-quinolyl)-2-pyrrolidinone
GB2087869B (en) Piperazine derivatives
GB2070603B (en) Piperazine compounds
AU544794B2 (en) 4-(2,2-dialkyl-indane-1-ylidene)-piperidines
AU549459B2 (en) 1-(trihalomethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5- ones and fungici-des containing same
GB2078222B (en) 4-(3-iodopropargyloxy)pyrimidines
EP0137395A3 (en) 4-(hydroxyphenylthio)-benzoates
GB2069497B (en) Piperazine compounds
GB2086387B (en) 1,8-dihydroxy-9-anthrones
EP0055347A3 (en) Dc stable memory
AU7877481A (en) 1-heteroalkyl,4-benzoyl substituted piperazines
ZA856586B (en) 1-(2-oxyaminosulphonylphenylsulphonyl)-3-heteroaryl-ureas
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
JPS56108766A (en) Piperazine derivative

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930522